Kallum Titchmarsh
Stock Analyst at Morgan Stanley
(n/a)
# 5,076
Out of 5,163 analysts
23
Total ratings
n/a
Success rate
-33.16%
Average return
Main Sectors:
Stocks Rated by Kallum Titchmarsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Overweight | $180 → $160 | $111.51 | +43.48% | 2 | Mar 3, 2026 | |
| WAT Waters | Maintains: Equal-Weight | $423 → $350 | $286.57 | +22.13% | 2 | Feb 23, 2026 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,550 → $1,475 | $1,173.74 | +25.67% | 2 | Feb 10, 2026 | |
| WST West Pharmaceutical Services | Initiates: Equal-Weight | $285 | $235.46 | +21.04% | 1 | Dec 2, 2025 | |
| INSP Inspire Medical Systems | Downgrades: Equal-Weight | $105 → $130 | $58.62 | +121.77% | 7 | Dec 2, 2025 | |
| DHR Danaher | Initiates: Overweight | $270 | $187.32 | +44.14% | 1 | Dec 2, 2025 | |
| PEN Penumbra | Maintains: Equal-Weight | $260 → $266 | $336.18 | -20.88% | 8 | Jul 31, 2025 |
Agilent Technologies
Mar 3, 2026
Maintains: Overweight
Price Target: $180 → $160
Current: $111.51
Upside: +43.48%
Waters
Feb 23, 2026
Maintains: Equal-Weight
Price Target: $423 → $350
Current: $286.57
Upside: +22.13%
Mettler-Toledo International
Feb 10, 2026
Maintains: Equal-Weight
Price Target: $1,550 → $1,475
Current: $1,173.74
Upside: +25.67%
West Pharmaceutical Services
Dec 2, 2025
Initiates: Equal-Weight
Price Target: $285
Current: $235.46
Upside: +21.04%
Inspire Medical Systems
Dec 2, 2025
Downgrades: Equal-Weight
Price Target: $105 → $130
Current: $58.62
Upside: +121.77%
Danaher
Dec 2, 2025
Initiates: Overweight
Price Target: $270
Current: $187.32
Upside: +44.14%
Penumbra
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $260 → $266
Current: $336.18
Upside: -20.88%